Evaxion - PE Ratio 2020-2025 | EVAX

Current and historical p/e ratio for Evaxion - (EVAX) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evaxion - PE ratio as of July 23, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Evaxion - PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-23 2.68 0.00
2025-03-31 1.85 $-21.39 0.00
2024-06-30 14.50 $-33.60 0.00
2023-06-30 65.50 $-52.50 0.00
2022-06-30 96.00 $-55.50 0.00
2022-03-31 151.50 $-63.50 0.00
2021-12-31 221.00 $-62.50 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.738B 59.46
Hims & Hers Health (HIMS) United States $12.987B 134.93
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $11.228B 0.00
IRhythm Technologies (IRTC) United States $4.298B 0.00
Inspire Medical Systems (INSP) United States $3.880B 60.62
Hinge Health (HNGE) United States $3.671B 0.00
Privia Health (PRVA) United States $2.475B 169.17
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.690B 0.00
10x Genomics (TXG) United States $1.677B 0.00
Phreesia (PHR) United States $1.648B 0.00
Enovis (ENOV) United States $1.582B 8.82
Azenta (AZTA) United States $1.578B 73.36
Omnicell (OMCL) United States $1.321B 23.31
Evolent Health (EVH) United States $1.199B 102.10
Claritev (CTEV) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.575B 0.00
Standard BioTools (LAB) United States $0.551B 0.00
Butterfly Network (BFLY) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Talkspace (TALK) United States $0.438B 131.00
TruBridge (TBRG) United States $0.347B 770.33
Outset Medical (OM) United States $0.345B 0.00
Health Catalyst (HCAT) United States $0.282B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.197B 0.00
Zepp Health (ZEPP) Netherlands $0.176B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.134B 0.00
MDxHealth SA (MDXH) Belgium $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.105B 3.98
Insight Molecular Diagnostics (IMDX) United States $0.086B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00